US 9260515
Antibodies to human GDF8
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 9260515 (Antibodies to human GDF8) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61P, A61P1/00